News

Boehringer obtains development and commercialisation rights to ZP2929 – Zealand Pharma’s glucagon/GLP-1 dual agonist drug candidate. Under the agreement, Zealand Pharma will be responsible for conducting the first

The trial results demonstrated that the vaccine was safe and well tolerated through out the study which involved around 200 healthy volunteers. The vaccine, when used in combination

Tripos’ molecular modeling software portfolio will be used for target identification, lead identification and leadoptimization. Moulder Center director Magid Abou-Gharbia said that it has set up a laboratory

West Pharma will start production in the new plant in January 2013. West Pharma’s new facility will be adjacent to its injection molding facility which was established in

Menveo is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y. The sBLA is supported by data from

ProArray Ultra, with its sensitivity and flexibility, overcomes the traditional trade-off between optimized 96-well plate-based assays, which are reliable and have good performance characteristics but lack the required

Under an agreement signed between the companies, Cosmocel Quimica’s Monterrey, Mexico-based manufacturing facility will be purchased by ICL, including its sales and distribution network in Mexico, Central and

Goanna is indiacted for the relief of muscular aches and pains and other conditions such as arthritis. The acquisition allows Generic Health to get the worldwide rights to

The offering combines the benefits of CEVEC’s human cell line and CAP-technology with Catalent’s gene product expression (GPEx) technology to generate stable human cell lines in a much